Pharma & Biotech

First reported Sep 20 2014 - Updated 8 hours ago - 10 reports

British GSK fined USD490m by China on bribery

(MENAFN) British drugmaker GlaxoSmithKline (GSK) has been fined around USD490 million by a Chinese court following a one-year old bribery investigation, ... [Published MENAFN - 8 hours ago]
First reported Sep 19 2014 - Updated Sep 20 2014 - 147 reports

GSK fined £297m over Chinese doctor bribery case

The Chinese authorities slapped the penalty on Glaxo after launching an investigation in June last year into practices by executives in its Chinese business.A Chinese court said Glaxo had "resorted to bribery to boost sales of its medical products and ... [Published Daily Express - Sep 20 2014]
First reported Sep 19 2014 - Updated Sep 20 2014 - 8 reports

Eli Lilly's Trulicity receives US FDA approval to treat adults with type 2 diabetes

Eli Lilly and Company announced that the approval of Trulicity (dulaglutide) by the US Food and Drug Administration is the latest treatment option for adults with type 2 diabetes.Trulicity is indicated as an adjunct to diet and exercise to improve glycemic ... [Published PharmaBiz - Sep 20 2014]
First reported Sep 19 2014 - Updated Sep 20 2014 - 4 reports

Rajasthan to train drug inspectors following NPPA's plan to set up price modulating cells

Following National Pharmaceutical Pricing Authority (NPPA)'s plan to set up price modulating cells in each of the state drug control departments, Rajasthan State Drug Control department will be training drug inspectors for monitoring prices of drugs and ... [Published PharmaBiz - Sep 20 2014]
First reported Sep 19 2014 - Updated Sep 20 2014 - 11 reports

EU Approval Of Gilead Sciences, Inc.'s Zydelig Nothing But Good News, Says Analyst

September 17, 2014By Riley McDermid , BioSpace.com Breaking News Sr.EditorNews that the European Commission has approved Gilead Sciences, Inc. 's ( GILD ) drug Zydelig for two blood cancers means nothing but upside for investors, an analyst with Guggenheim ... [Published BioSpace - Sep 20 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 3 reports

Pfizer Foundation Provides $2 Million In Grants To Support ???Last-Mile??? Vaccine Coverage In Africa

NEW YORK--(BUSINESS WIRE)--The Pfizer Foundation today announced $2 million in grant funding for pilot programs to improve immunization coverage in Africa. The programs will focus on ‘last-mile’ interventions to reach underserved populations living in ... [Published BioSpace - Sep 19 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 5 reports

Horizon Pharma completes acquisition of Vidara Therapeutics International plc

3:43pm BSTHorizon Pharma:Completed the acquisition of Vidara Therapeutics International plc.Says in connection with the acquisition, Horizon and Vidara have combined with the resulting parent company incorporated in Ireland and named Horizon Pharma Public ... [Published Reuters UK - Sep 19 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 2 reports

Null Findings on Selenium Supplements for Cataract Prevention

Jeannette Y. Wick, RPh, MBA, FASCPSelenium supplementation has been studied as a potential prophylactic measure for thyroid disease and various types of cancer, but its role in cataract prevention is of particular interest to researchers, considering ... [Published Pharmacy Times - Sep 19 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 6 reports

Novo finds new way to sell Tresiba in EU while awaiting another shot in U.S.

Xultophy is a combo of Tresiba and VictozaShareToolsNovo Nordisk ($NVO) is hustling to get work done so that it can resubmit its blockbuster hopeful Tresiba to the FDA next year with an eye on getting into the market by 2016, three years after the FDA ... [Published FiercePharma - Sep 19 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 8 reports

Type 2 diabetes market to increase to $47 billion in 2023

As physicians continue to adopt a more individualized approach to patient care, branded type 2 diabetes therapies continue to experience increased use despite attempts by payer and reimbursement authorities to limit use of these more expensive drugs, ... [Published Pharma Letter - Sep 19 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 4 reports

Swedish Orphan Biovitrum adds new molecule to its hemophilia collaboration with Biogen Idec

Nordic biotech firm Swedish Orphan Biovitrum (STO: SOBI) has added the preclinical fusion molecule rFVIIIFc-XTEN-vWF for hemophilia to its collaboration with US biotech firm Biogen Idec (Nasdaq: BIIB). The technology is proprietary to Amunix Operating, ... [Published Pharma Letter - Sep 19 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 5 reports

FDA calls for tighter controls over testosterone replacement therapies

An advisory panel of the US Food and Drug Administration has voted to tighten use of testosterone replacement drugs.On Wednesday the panel voted 20-1 to restrict the use of testosterone replacement therapies to people who have low testosterone because ... [Published Pharma Letter - Sep 19 2014]

Quotes

Positively, lower real-world drop-out rates seen with Sovaldi when used as part of an all-oral combination (with Johnson & Johnson's Olysio) could "be an incremental driver of an improved realised price per patient" for Gilead's Sovaldi plus ledipasvir combination, remarked analysts at Credit Suisse...
...A large pension fund manager told the paper: "There is a casual disregard for shareholders in the oil industry."
...challenging and dangerous situation in Sierra Leone," said Leslie Scott, national director of World Vision Sierra Leone, in a press release. "These medical supplies will support the men and women who are putting their lives on the line to respond to the Ebola crisis."
"We knew coming in that we had a strong team - it was just a matter of everything falling into place. We went out there, did our thing, stayed calm, and we delivered."

More Content

All (31674) | News (31326) | Reports (1) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (62)
sort by: Date | Relevance
Infographic – Can Eli Lilly turn up the competi... [Published FirstWord Pharma - 14 mins ago]
The Friday Five – 5 questions raised last week ... [Published FirstWord Pharma - 17 mins ago]
Sunday newspaper round-up: Lloyds, Marks&Spence... [Published BullBearings - 19 mins ago]
AmpliPhi BioSciences CEO Philip Young resigns [Published KansasCity.com - 37 mins ago]
AmpliPhi BioSciences CEO Philip Young resigns [Published Belleville News Democrat - 39 mins ago]
Medical Supplies Flood into Sierra Leone During... [Published Pharmacy Times - 54 mins ago]
The 10.0 Report: Telecom and Pharma Hold Top Spots [Published State Of The Markets.com - 56 mins ago]
Cycling-BMC beat holders Omega Pharma to claim ... [Published Mail Online UK - 1 hour ago]
Bill Maher Blasts Fear-Mongering Over ISIS: 'Un... [Published Huffington Post - 1 hour ago]
Brand Name Pharmaceutical Manufacturing in Cana... [Published Insurance News Net - 2 hours ago]
ExpertPages 2014 Survey Reports Expert Witness ... [Published BioSpace - 2 hours ago]
Waldorf Risk Solutions Releases New Risk Manage... [Published BioSpace - 2 hours ago]
Your Views for September 21 [Published Hawaii Tribune-Herald - 2 hours ago]
Guru Stocks at 52-Week Lows: BHP, GSK, EC, VALE... [Published Guru Focus - 2 hours ago]
EQUITY ALERT: The Rosen Law Firm Announces Fili... [Published Scottrade - 2 hours ago]
Sunday share tips: GlaxoSmithKline, African Min... [Published London South East - 3 hours ago]
Physician-Pharmacist Collaboration Keeps Asthma... [Published Pharmacy Times - 3 hours ago]
Acetone breath from a high-fat ketogenic diet [Published Seattle Times - 3 hours ago]
Adventures in Flagstaff bioscience [Published Arizona Daily Sun - 3 hours ago]
Career Zoo: Interview with Killian O’Driscoll, ... [Published Silicon Republic - 3 hours ago]
Competitor Analysis: Rabies Virus Vaccines, Ant... [Published PipelineReview - 3 hours ago]
Senior Research Associate, Virology (#433) - Ba... [Published BIO - 4 hours ago]
Another Independent Study Confirms Monsanto’s R... [Published PrisonPlanet - 4 hours ago]
New skin cancer drug could be come available fo... [Published Plymouth Herald - 4 hours ago]
On occasion of World CML Awareness Day, doctors... [Published WAM.ae - 5 hours ago]
CLINICAL TRIAL BEGINS FOR LEUKEMIA DRUG [Published U-T San Diego - 5 hours ago]
China Fines British Company 3 Billion Yuan [Published Tempo.co - 6 hours ago]
Nile Pharmaceuticals general meeting Oks financ... [Published Mubasher - 6 hours ago]
Glaxo receives record fine in China [Published Digital Journal - 6 hours ago]
Drugstores, retailers take shot at vaccines [Published North West Arkansas Times - 6 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
From Sprint And TechStars To The FDA, A Look At... [Published TechCrunch - Oct 10 2013]
The health-care industry in the U.S. is broken, and considering the industry itself represents some 18 percent of the U.S. economy, it’s a sizable problem. While other sectors have begun to adapt, health care has managed to resist change — particularly ...
1

Press Releases

sort by: Date | Relevance
Using genomics to make personalized, safer medi... [Published PR Newswire - Feb 03 2014]
Endo Completes Acquisition of Specialty Generic... [Published PR Newswire - Feb 03 2014]
10 Reasons Why Biometric Exit May Advance in 2014 [Published PR Newswire - Feb 03 2014]
Regado Biosciences Announces $20 Million Privat... [Published PR Newswire - Jan 31 2014]
Novo Nordisk Promotes Eddie Williams to Senior ... [Published PR Newswire - Jan 30 2014]
1 2 3 4 5 6 7 8 9 10 ...
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.